StockData
Surrozen, Inc./DE logo

Surrozen, Inc./DE (SRZN) stock

SRZNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/30
$29.98−2.34 (-7.24%)

Close on Nov 17, 2026Market cap $352.37MP/E –Yield –

Earnings

Surrozen's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 22, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q2 FY2026
$5.00M
+400.0% on a year earlier
EPS, Q2 FY2026
-$0.41
$2.55 a year earlier
Latest guidance
Issued
Mar 22, 2023 · 1 item

Quarterly results

Revenue and earnings per share from each of Surrozen's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 22, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 9, 2026after the close–––Release
Q2 FY2026ended Jun 30, 2026Aug 6, 2026after the close$5.00M+400.0%-$0.41Release
Q1 FY2026ended Mar 31, 2026May 6, 2026after the close$5.00M+400.0%-$11.65Release
Q4 FY2025ended Dec 31, 2025Mar 23, 2026after the close$500.00K–-$20.13Release
Q3 FY2025ended Sep 30, 2025Nov 7, 2025after the close$983.00K-90.2%-$8.36Release
Q2 FY2025ended Jun 30, 2025Aug 8, 2025after the close$1.00M–$2.55Release
Q1 FY2025ended Mar 31, 2025May 9, 2025after the close$1.00M–-$7.43Release
Q4 FY2024ended Dec 31, 2024Mar 31, 2025after the close–––Release
Q3 FY2024ended Sep 30, 2024Nov 6, 2024before the open$10.00M–-$0.44Release
Q2 FY2024ended Jun 30, 2024Aug 12, 2024after the close––-$7.99Release
Q3 FY2023ended Sep 30, 2023Nov 8, 2023after the close––-$0.34Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

No open guidance: every period Surrozen guided for has been reported

Guidance history

Every forecast Surrozen put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Mar 22, 2023operating expenses, excluding non-cash and non-recurring chargesFY2023+15%New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Surrozen filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Results
  5. Results
  6. Results
  7. Results
  8. Results
  9. Results
  10. Update
  11. Update
  12. Results
  13. Results
  14. Results
  15. Update

See a number that looks wrong?